These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8521149)

  • 1. Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss.
    Guare JC; Wing RR; Grant A
    Obes Res; 1995 Jul; 3(4):329-35. PubMed ID: 8521149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
    Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes.
    Pascale RW; Wing RR; Butler BA; Mullen M; Bononi P
    Diabetes Care; 1995 Sep; 18(9):1241-8. PubMed ID: 8612437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of NIDDM on the kinetics of whole-body protein metabolism.
    Gougeon R; Pencharz PB; Marliss EB
    Diabetes; 1994 Feb; 43(2):318-28. PubMed ID: 8288057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus.
    Park JY; Lee KU; Kim CH; Kim HK; Hong SK; Park KS; Lee HK; Min HK
    Diabetes Res Clin Pract; 1997 Feb; 35(1):49-56. PubMed ID: 9113475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) in android obesity and NIDDM.
    Wassef N; Sidhom G; Zakareya el-K ; Mohamed el-K
    Diabetes Care; 1997 Nov; 20(11):1693-6. PubMed ID: 9353610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
    Low CC; Grossman EB; Gumbiner B
    Diabetes; 1996 May; 45(5):569-75. PubMed ID: 8621005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exercise intensity on glucose and insulin metabolism in obese individuals and obese NIDDM patients.
    Kang J; Robertson RJ; Hagberg JM; Kelley DE; Goss FL; DaSilva SG; Suminski RR; Utter AC
    Diabetes Care; 1996 Apr; 19(4):341-9. PubMed ID: 8729157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.
    Chow CC; Ko GT; Tsang LW; Yeung VT; Chan JC; Cockram CS
    Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.
    Wing RR; Blair EH; Bononi P; Marcus MD; Watanabe R; Bergman RN
    Diabetes Care; 1994 Jan; 17(1):30-6. PubMed ID: 8112186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of health beliefs on weight loss in individuals at high risk for NIDDM.
    Polley BA; Jakicic JM; Venditti EM; Barr S; Wing RR
    Diabetes Care; 1997 Oct; 20(10):1533-8. PubMed ID: 9314630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food-containing hypocaloric diets are as effective as liquid-supplement diets for obese individuals with NIDDM.
    Anderson JW; Brinkman-Kaplan V; Hamilton CC; Logan JE; Collins RW; Gustafson NJ
    Diabetes Care; 1994 Jun; 17(6):602-4. PubMed ID: 8082533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.
    Henry RR; Wiest-Kent TA; Scheaffer L; Kolterman OG; Olefsky JM
    Diabetes; 1986 Feb; 35(2):155-64. PubMed ID: 3510922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
    Polonsky KS; Gumbiner B; Ostrega D; Griver K; Tager H; Henry RR
    Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus.
    Kelley DE; Wing R; Buonocore C; Sturis J; Polonsky K; Fitzsimmons M
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1287-93. PubMed ID: 8077323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less fat reduction per unit weight loss in type 2 diabetic compared with nondiabetic obese individuals completing a very-low-calorie diet program.
    Baker ST; Jerums G; Prendergast LA; Panagiotopoulos S; Strauss BJ; Proietto J
    Metabolism; 2012 Jun; 61(6):873-82. PubMed ID: 22146094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients.
    Avellone G; di Garbo V; Cordova R; Rotolo G; Raneli G; de Simone R; Bompiani G
    Metabolism; 1997 Aug; 46(8):930-4. PubMed ID: 9258277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes.
    Curto M; Novi RF; Rabbone I; Maurino M; Piccinini M; Mioletti S; Mostert M; Bruno R; Rinaudo MT
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1137-42. PubMed ID: 9426381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.